United Laboratories Inc   Report issue

For profit Phase 2
Founded: St. Charles IL United States (1964)
Status: No NME R&D (1964)

Organization Overview

First Clinical Trial
2017
NCT03286101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

United Laboratories

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lice Infestations (Phase 2)

Tinea (Phase 2)

Tinea Pedis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 8